“THE POTENTIAL OF SIRNA ENCAPSULATED BY NANOPARTICLE AS SILENCING AGENT fOR SFLT-1 AND NRF-2: Effective Therapy Inovation against Preeclampsia”, JIMKI, vol. 9, no. 3, pp. 34–41, Apr. 2022, doi: 10.53366/jimki.v9i3.433.